Suncoast Equity Management’s AbbVie ABBV Stock Holding History

Suncoast Equity Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Buy	+5,438	New	+$1.17M	0.17%	40
2022 Q2	–	Sell	-7,716	Closed	-$1.25M	–	57
2022 Q1	$1.25M	Buy	7,716 +486	+7%	+$70.6K	0.19%	27
2021 Q4	$979K	Buy	7,230 +420	+6%	+$49.6K	0.12%	28
2021 Q3	$735K	Sell	6,810 -640	-9%	-$73.1K	0.1%	29
2021 Q2	$839K	Buy	7,450 +1,615	+28%	+$182K	0.11%	27
2021 Q1	$631K	Buy	5,835 +105	+2%	+$11.2K	0.09%	29
2020 Q4	$614K	Buy	5,730 +445	+8%	+$42.8K	0.1%	29
2020 Q3	$463K	Buy	5,285 +200	+4%	+$18.8K	0.08%	28
2020 Q2	$499K	Buy	5,085 +800	+19%	+$70.4K	0.09%	26
2020 Q1	$326K	Buy	+4,285	New	+$365K	0.08%	30
2014 Q2	–	Sell	-53,745	Closed	-$2.76M	–	21
2014 Q1	$2.76M	Buy	53,745 +805	+2%	+$40.7K	2.79%	17
2013 Q4	$2.8M	Buy	52,940 +2,135	+4%	+$105K	2.84%	17
2013 Q3	$2.27M	Sell	50,805 -553	-1%	-$24.5K	2.66%	16
2013 Q2	$2.12M	Buy	+51,358	New	+$2.25M	2.71%	16

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Suncoast Equity Management's ABBV Position: Q2 2026 in Review

Suncoast Equity Management opened a new position in AbbVie (ABBV) in Q2 2026: 5,438 shares worth $1.37M. The stake represents 0.17% of the portfolio and ranks #40 among its holdings. This is a return to the name: Suncoast Equity Management previously reported a position in ABBV as recently as Q1 2022.

Suncoast Equity Management first reported a position in ABBV in Q2 2013 and has held it in 14 quarters since. The position peaked at $2.8M in Q4 2013. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Suncoast Equity Management held 5,438 shares of AbbVie worth $1.37M as of Q2 2026.
AbbVie was a new Suncoast Equity Management position in Q2 2026.
AbbVie made up 0.17% of Suncoast Equity Management's portfolio in Q2 2026, its #40 holding.
Suncoast Equity Management first reported a position in AbbVie in Q2 2013 and has held it in 14 quarters since.
Suncoast Equity Management's AbbVie position peaked at $2.8M in Q4 2013.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Suncoast Equity Management's 13F filing for Q2 2026, filed 4 Aug 2026.